Skip to main content
. 2018 Aug 28;19(9):2545. doi: 10.3390/ijms19092545
ABCA1/G1 ATP-binding cassette A1/G1
ADT androgen deprivation therapy
AF1/2 activating function 1/2
AR androgen receptor
COX2 cyclooxygenase 2
DHT dihydrotestosterone
CRPC castration-resistant prostate cancer
mCRPC metastatic CRPC
ER estrogen receptor
EST estrogen sulfotransferase
EZH2 enhancer of Zeste homolog 2
Her-2/neu receptor tyrosine-protein kinase erbB-2
HMGCR hydroxy-3-methylglutaryl-coenzyme A reductase
IDOL inducible degrader of the LDL receptor
iNOS inducible nitric oxide synthase
JAK/STAT Janus kinase/signal transducers and activators of transcription
LDLR LDL receptor
LXR liver X receptor
MAPK mitogen-activated protein kinases
MSMB beta-microseminoprotein
NKX3.1 homeobox protein Nkx-3.1
NR nuclear receptor
PCa prostate cancer
PI3K phosphoinositide 3-kinase
PSA prostate specific antigen
RXR retinoid X receptor
SOCS3 suppressor of cytokine signaling 3
SR5A2 5α-reductase type 2
SREBP sterol response element binding protein
SLiMs selective liver X receptor modulators
SULT2A1 sulfotransferase family 2A member 1
VEGF vascular endothelial growth factor
Wnt Wingless/Integrated